CLINICAL_TRIALS
trial_result
· 2022-05-12
Clinical Trial Update: Efficacy of Primary Debulking Surgery Versus Neoadjuvant Chemotherapy in Stage IV Ovarian Cancer [Phase 3]
Summary
Phase 3 trial comparing primary debulking surgery to neoadjuvant chemotherapy for stage IV ovarian cancer.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Fudan University | Conditions: Ovarian Cancer | Phase 3 | Status: UNKNOWN